Citi initiates coverage on Schering-Plough (NYSE: SGP) with a Neutral. Price target $23.

Citi analyst says, "U.S. cholesterol ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE